[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.176.35. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
March 5, 2003

Estrogen Replacement and Risk of Alzheimer DiseaseEstrogen Replacement and Risk of Alzheimer Disease

Author Affiliations
 

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2003;289(9):1100-1102. doi:10.1001/jama.289.9.1100-a

To the Editor: Dr Zandi and colleagues1 argue that underreporting of HRT use among women who subsequently develop AD is unlikely because of the "notable nature of a decision to use HRT and the tendency of women to use HRT for an extended period of time." Furthermore, the authors note no relationships between "control exposures" (ie, calcium and multivitamins) and the incidence of AD. The authors conclude it is unlikely that women who later developed dementia would have selectively forgotten making a "carefully considered decision to use HRT."

First Page Preview View Large
First page PDF preview
First page PDF preview
×